FDA OKs Apomorphine Sublingual Film for 'Off' Episodes in PD

The FDA has approved apomorphine hydrochloride (Kynmobi) sublingual film as the first treatment of its kind for ‘off’ episodes in patients with Parkinson’s disease.
FDA Approvals

Source link

Related posts

Neuronal intranuclear inclusion disease showing intranuclear inclusions in renal biopsy 12 years earlier


From the overuse of antibiotics to anti-vaxxers, why we need to work together to create a stronger culture of public health


Efgartigimod: A novel antibody depletion therapy in myasthenia gravis


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World